Dr. Katharine Ashley Whartenby is associate professor in the The Johns Hopkins University School of Medicine Department of Neurology, Department of Oncology and in Cellular and Molecular Medicine.
Her research focuses on understanding the biology of multiple sclerosis and neuroimmunology. Dr. Whartenby has patents pending for Immune modulation through targeting of the MINOR gene and for use of FLT3 inhibitors as immunosuppressants. Her team is currently engaged in analyzing immunological mechanisms by which people with multiple sclerosis suffer from infectious disease complications.
Dr. Whartenby received her bachelor of arts in biology and english, Cum Laude, at Amherst College in Amherst, Massachusetts. She earned a Ph.D. in microbiology and immunology at the University of Rochester in New York, and also completed a post-doctoral fellowship in immunology at the University of Rochester. Dr. Whartenby joined the Johns Hopkins faculty in 2003.
Prior to joining Johns Hopkins, Dr. Whartenby was a microbiologist at the Food and Drug Administration as well as an assistant professor of medicine at Brown University School of Medicine in Providence, Rhode Island.
She is an active member of the American Association for Cancer Research and the American Association of Immunologists.